Joshua A Salomon

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. pmc Clinical benefits, costs, and cost-effectiveness of neonatal intensive care in Mexico
    Jochen Profit
    Department of Pediatrics, Section of Neonatology, Texas Children s Hospital, Baylor College of Medicine, Houston, Texas, United States of America
    PLoS Med 7:e1000379. 2010
  2. doi request reprint Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010
    Joshua A Salomon
    Harvard School of Public Health, Harvard University, Boston, MA 02115, USA
    Lancet 380:2144-62. 2012
  3. ncbi request reprint Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010
    Joshua A Salomon
    Harvard School of Public Health, MA, USA
    Lancet 380:2129-43. 2012
  4. pmc Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis
    Joshua A Salomon
    Department of Global Health and Population, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA
    BMJ 344:e355. 2012
  5. ncbi request reprint A multi-method approach to measuring health-state valuations
    Joshua A Salomon
    Evidence and Information for Policy, World Health Organization, Geneva, Switzerland
    Health Econ 13:281-90. 2004
  6. doi request reprint Comparability of patient-reported health status: multicountry analysis of EQ-5D responses in patients with type 2 diabetes
    Joshua A Salomon
    Department of Global Health and Population, Harvard School of Public Health, Boston, MA 02115, USA
    Med Care 49:962-70. 2011
  7. pmc Are Americans feeling less healthy? The puzzle of trends in self-rated health
    Joshua A Salomon
    Harvard University Initiative for Global Health, Cambridge, MA 02138, USA
    Am J Epidemiol 170:343-51. 2009
  8. doi request reprint Evaluating the impact of antiretroviral therapy on HIV transmission
    Joshua A Salomon
    Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS 22:S149-59. 2008
  9. pmc Prospects for advancing tuberculosis control efforts through novel therapies
    Joshua A Salomon
    Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS Med 3:e273. 2006
  10. pmc Integrating HIV prevention and treatment: from slogans to impact
    Joshua A Salomon
    Harvard Center for Population and Development Studies, Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, USA
    PLoS Med 2:e16. 2005

Detail Information

Publications56

  1. pmc Clinical benefits, costs, and cost-effectiveness of neonatal intensive care in Mexico
    Jochen Profit
    Department of Pediatrics, Section of Neonatology, Texas Children s Hospital, Baylor College of Medicine, Houston, Texas, United States of America
    PLoS Med 7:e1000379. 2010
    ..The purpose of this study was to estimate the clinical outcomes, costs, and cost-effectiveness of neonatal intensive care in Mexico...
  2. doi request reprint Healthy life expectancy for 187 countries, 1990-2010: a systematic analysis for the Global Burden Disease Study 2010
    Joshua A Salomon
    Harvard School of Public Health, Harvard University, Boston, MA 02115, USA
    Lancet 380:2144-62. 2012
    ..These comparisons can inform policy questions that depend on how morbidity changes as mortality decreases. We characterise current HALE and changes over the past two decades in 187 countries...
  3. ncbi request reprint Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010
    Joshua A Salomon
    Harvard School of Public Health, MA, USA
    Lancet 380:2129-43. 2012
    ....
  4. pmc Intervention strategies to reduce the burden of non-communicable diseases in Mexico: cost effectiveness analysis
    Joshua A Salomon
    Department of Global Health and Population, Harvard School of Public Health, 665 Huntington Avenue, Boston, MA 02115, USA
    BMJ 344:e355. 2012
    ..To inform decision making regarding intervention strategies against non-communicable diseases in Mexico, in the context of health reform...
  5. ncbi request reprint A multi-method approach to measuring health-state valuations
    Joshua A Salomon
    Evidence and Information for Policy, World Health Organization, Geneva, Switzerland
    Health Econ 13:281-90. 2004
    ....
  6. doi request reprint Comparability of patient-reported health status: multicountry analysis of EQ-5D responses in patients with type 2 diabetes
    Joshua A Salomon
    Department of Global Health and Population, Harvard School of Public Health, Boston, MA 02115, USA
    Med Care 49:962-70. 2011
    ..Valid and comparable measures of health outcomes are needed for clinical trials, studies on quality of healthcare, and population health monitoring...
  7. pmc Are Americans feeling less healthy? The puzzle of trends in self-rated health
    Joshua A Salomon
    Harvard University Initiative for Global Health, Cambridge, MA 02138, USA
    Am J Epidemiol 170:343-51. 2009
    ..More work is urgently needed on robust and comparable approaches to tracking population health...
  8. doi request reprint Evaluating the impact of antiretroviral therapy on HIV transmission
    Joshua A Salomon
    Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS 22:S149-59. 2008
    ....
  9. pmc Prospects for advancing tuberculosis control efforts through novel therapies
    Joshua A Salomon
    Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS Med 3:e273. 2006
    ..As new candidates emerge from the global TB drug pipeline, the potential impacts of novel, shorter regimens on TB incidence and mortality have not yet been examined...
  10. pmc Integrating HIV prevention and treatment: from slogans to impact
    Joshua A Salomon
    Harvard Center for Population and Development Studies, Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, USA
    PLoS Med 2:e16. 2005
    ..In this paper, we quantify the opportunities and potential risks of large-scale treatment roll-out...
  11. pmc Taking account of future technology in cost effectiveness analysis
    Joshua A Salomon
    Department of Population and International Health, Harvard School of Public Health, Harvard Center for Population and Development Studies, 9 Bow Street, Cambridge MA 02138, USA
    BMJ 329:733-6. 2004
  12. pmc Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes
    Joshua A Salomon
    Department of Population and International Health, Center for Population and Development Studies, Harvard School of Public Health, 9 Bow Street, Cambridge, MA 02138, USA
    BMJ 328:258. 2004
    ..To examine differences in expectations for health using anchoring vignettes, which describe fixed levels of health on dimensions such as mobility...
  13. ncbi request reprint Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population
    Joshua A Salomon
    Harvard Center for Population and Development Studies, Cambridge, Mass 02138, USA
    JAMA 290:228-37. 2003
    ..Approximately 2.7 million US individuals are chronically infected with the hepatitis C virus (HCV). As public health campaigns are pursued, a growing number of treatment candidates are likely to have minimal evidence of liver damage...
  14. pmc Global patterns of healthy life expectancy in the year 2002
    Colin D Mathers
    Evidence and Information for Policy, World Health Organization, Avenue Appia, Geneva, Switzerland
    BMC Public Health 4:66. 2004
    ..The World Health Organization reports on healthy life expectancy for 192 WHO Member States. This paper describes variation in average levels of population health across these countries and by sex for the year 2002...
  15. pmc Cost-effectiveness of treating multidrug-resistant tuberculosis
    Stephen C Resch
    Department of Health Policy and Management, Harvard School of Public Health, Harvard University, Boston, Massachusetts, United States of America
    PLoS Med 3:e241. 2006
    ..We projected the health benefits and cost-effectiveness of using drug susceptibility testing and second-line drugs in a lower-middle-income setting with high levels of MDR TB...
  16. pmc Cost-effectiveness of treatment for hepatitis C in an urban cohort co-infected with HIV
    Nicole G Campos
    Program in Health Policy, Harvard University, Cambridge, Mass, USA
    Am J Med 120:272-9. 2007
    ..Our objective was to use these data to examine the cost-effectiveness of treating HCV in an urban cohort of co-infected patients...
  17. doi request reprint Disease burden and mental health system capacity: WHO Atlas study of 117 low- and middle-income countries
    Ryan McBain
    Department of Global Health and Population, Harvard School of Public Health, 651 Huntington Avenue, Boston, MA 02115, USA
    Br J Psychiatry 201:444-50. 2012
    ..Studies have yet to examine whether the capacity of mental health systems might be adversely affected by the burdens of unrelated conditions such as HIV/AIDS...
  18. pmc Cost-effectiveness of Rotavirus vaccination in Vietnam
    Sun Young Kim
    Department of Health Policy and Management, Harvard School of Public Health, Boston, MA, USA
    BMC Public Health 9:29. 2009
    ..g., the possibility of reinfection and varying degrees of partial immunity conferred by natural infection), and assess the influence of the features on the cost-effectiveness of rotavirus vaccination...
  19. ncbi request reprint Healthy life expectancy: comparison of OECD countries in 2001
    Colin D Mathers
    Global Program on Evidence for Health Policy, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland
    Aust N Z J Public Health 27:5-11. 2003
    ..To compare average levels of population health for Australia and other OECD countries in 2001...
  20. ncbi request reprint The hepatitis C cascade of care: identifying priorities to improve clinical outcomes
    Benjamin P Linas
    HIV Epidemiology and Outcomes Research Unit, Section of Infectious Diseases, Boston Medical Center, Boston, Massachusetts, United States of America Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America
    PLoS ONE 9:e97317. 2014
    ..We used simulation modeling to estimate the impact of loss to follow-up on HCV treatment outcomes and to identify intervention strategies likely to provide good value for the resources invested in them...
  21. pmc National HIV prevalence estimates for sub-Saharan Africa: controlling selection bias with Heckman-type selection models
    Daniel R Hogan
    Harvard School of Public Health, Department of Global Health and Population, 665 Huntington Ave, Building 1, Boston, MA 02115, USA
    Sex Transm Infect 88:i17-23. 2012
    ..We control for selection bias in national HIV prevalence estimates using a novel approach, which unlike conventional imputation can account for selection on unobserved factors...
  22. ncbi request reprint Global patterns of healthy life expectancy for older women
    Colin D Mathers
    Global Programme on Evidence for Health Policy, World Health Organization, Geneva, Switzerland
    J Women Aging 14:99-117. 2002
    ..We discuss the implications of the findings for international health policy...
  23. pmc Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination
    Jeremy D Goldhaber-Fiebert
    Doctoral Program in Health Policy, Decision Science Concentration, Harvard University, Cambridge, MA, USA
    J Natl Cancer Inst 100:308-20. 2008
    ....
  24. pmc Household and community socioeconomic and environmental determinants of child nutritional status in Cameroon
    Roland Pongou
    Harvard School of Public Health, Boston, MA, USA
    BMC Public Health 6:98. 2006
    ..We further consider age-specific effects of household economic status on child nutrition...
  25. pmc Flexible epidemiological model for estimates and short-term projections in generalised HIV/AIDS epidemics
    Daniel R Hogan
    Center for Health Decision Science, Harvard School of Public Health, 718 Huntington Avenue, Boston, MA 02115, USA
    Sex Transm Infect 86:ii84-92. 2010
    ..Our objective was to develop modifications to the current model that improve fit to recently observed prevalence trends across countries...
  26. doi request reprint Exploring model uncertainty in economic evaluation of health interventions: the example of rotavirus vaccination in Vietnam
    Sun Young Kim
    Center for Health Decision Science, Harvard School of Public Health, Boston, MA, USA
    Med Decis Making 30:E1-E28. 2010
    ....
  27. pmc Cost effectiveness analysis of strategies to combat HIV/AIDS in developing countries
    Daniel R Hogan
    Harvard Center for Population and Development Studies, Harvard School of Public Health, Cambridge, MA 02138, USA
    BMJ 331:1431-7. 2005
    ..To assess the costs and health effects of a range of interventions for preventing the spread of HIV and for treating people with HIV/AIDS in the context of the millennium development goal for combating HIV/AIDS...
  28. pmc Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation
    Nicolas A Menzies
    Center for Health Decision Sciences, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS Med 9:e1001347. 2012
    ..As roll-out proceeds, it is essential to understand the potential health impact and cost-effectiveness of diagnostic strategies based on Xpert...
  29. doi request reprint Effects of healthcare reforms on coverage, access, and disparities: quasi-experimental analysis of evidence from Massachusetts
    Aakanksha H Pande
    Department of Population Medicine, Harvard Medical School, Boston, Massachusetts 02215, USA
    Am J Prev Med 41:1-8. 2011
    ..The potential impact of national healthcare reform may be considered using a similar set of state-level reforms including exchanges and a mandate, enacted in 2006 in Massachusetts...
  30. pmc Economic evaluation of hepatitis B vaccination in low-income countries: using cost-effectiveness affordability curves
    Sun Young Kim
    Program in Health Decision Science, Health Policy and Management Department, Harvard School of Public Health, Boston, MA 02115, USA
    Bull World Health Organ 85:833-42. 2007
    ..We sought to describe a method that explicitly considers both a health-care programmes cost-effectiveness and its affordability. For illustration, we apply the method to the programme to vaccinate infants against hepatitis B in the Gambia...
  31. ncbi request reprint Empirically calibrated model of hepatitis C virus infection in the United States
    Joshua A Salomon
    Global Programme on Evidence for Health Policy, World Health Organization, Geneva, Switzerland
    Am J Epidemiol 156:761-73. 2002
    ..These findings have important implications both for individual clinical decisions and for broader public health policy...
  32. doi request reprint Cost effectiveness of alternative surveillance strategies for hepatocellular carcinoma in patients with cirrhosis
    Karin L Andersson
    Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    Clin Gastroenterol Hepatol 6:1418-24. 2008
    ..We assessed the costs, clinical benefits, and cost effectiveness of US surveillance and alternative strategies for HCC in cirrhosis using a computer-based state transition model with parameters derived from available literature...
  33. pmc Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination
    Jeremy D Goldhaber-Fiebert
    Department of Health Policy and Management, Harvard School of Public Health, Boston, USA
    Popul Health Metr 5:11. 2007
    ..S. policy choices for cervical cancer prevention, we developed a model of human papillomavirus (HPV) and cervical cancer, explicitly incorporating uncertainty about the natural history of disease...
  34. pmc Evolution of antiretroviral drug costs in Brazil in the context of free and universal access to AIDS treatment
    Amy S Nunn
    Department of Population and International Health, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS Med 4:e305. 2007
    ..In this study, we investigate the drivers of recent ARV cost trends in Brazil through analysis of drug-specific prices and expenditures between 2001 and 2005...
  35. pmc Packaging health services when resources are limited: the example of a cervical cancer screening visit
    Jane J Kim
    Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS Med 3:e434. 2006
    ....
  36. pmc Spline-based modelling of trends in the force of HIV infection, with application to the UNAIDS Estimation and Projection Package
    Daniel R Hogan
    Harvard School of Public Health, Department of Global Health and Population, 665 Huntington Ave, Boston, MA 02115, USA
    Sex Transm Infect 88:i52-7. 2012
    ..Here, we test the feasibility of this approach for concentrated HIV/AIDS epidemics with very sparse data and compare two methods for making short-term future projections with the spline-based model...
  37. pmc Assessing the population health impact of market interventions to improve access to antiretroviral treatment
    Till Barnighausen
    Department of Global Health and Population, Harvard School of Public Health, Boston, MA 02115, USA
    Health Policy Plan 27:467-76. 2012
    ..We offer seven recommendations for ex ante and ex post assessment of population health impact of market interventions...
  38. pmc Non-monotonicity in the episodic random utility model
    Nicolas A Menzies
    Center for Health Decision Sciences, Harvard University, Boston, MA, USA
    Health Econ 20:1523-31. 2011
    ..These results present some challenge to the use of the eRUM estimator in generating health-state valuations for population health measurement and economic evaluation...
  39. pmc Prevention and treatment of human immunodeficiency virus/acquired immunodeficiency syndrome in resource-limited settings
    Daniel R Hogan
    Harvard Center for Population and Development Studies, Harvard School of Public Health, 9 Bow Street, Cambridge, MA 02138, USA
    Bull World Health Organ 83:135-43. 2005
    ..Successful integration of treatment and prevention of HIV/AIDS will require a balanced approach and rigorous monitoring of the impact of programmes in terms of both individual and population outcomes...
  40. ncbi request reprint Health impacts of macroeconomic crises and policies: determinants of variation in childhood malnutrition trends in Cameroon
    Roland Pongou
    Harvard School of Public Health, Boston, MA, USA
    Int J Epidemiol 35:648-56. 2006
    ..We examined the effects of economic crises and adjustment programmes during the 1990s in Cameroon on childhood malnutrition in population subgroups and evaluated the household and health system mediators of these effects...
  41. doi request reprint The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models
    Carel Pretorius
    aFutures Institute, Glastonbury, Connecticut bCenter for Health Decision Science, Harvard School of Public Health cDepartment of Global Health and Population, Harvard School of Public Health dDivision of Global Health Equity, Brigham and Women s Hospital eDepartment of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA fMRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology gDepartment of Infectious Disease Epidemiology, Imperial College London hDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK Carel Pretorius and Nicolas A Menzies contributed equally to the writing of this article
    AIDS 28:S25-34. 2014
    ..Previous studies suggest a wide range of possible TB impacts following ART expansion. We used three independently developed TB-HIV models to estimate the TB-related impact of expanding ART in South Africa...
  42. pmc Health-state valuations for pertussis: methods for valuing short-term health states
    Grace M Lee
    Center for Child Health Care Studies, Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School, 133 Brookline Ave, 6th Floor, Boston, MA 02215, USA
    Health Qual Life Outcomes 3:17. 2005
    ..S. Our objectives were: (1) to describe patient valuations of pertussis disease and vaccination; and (2) to compare valuations for short-term and long-term health states associated with pertussis...
  43. pmc Preferences for health outcomes associated with Group A Streptococcal disease and vaccination
    Grace M Lee
    Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 133 Brookline Avenue, Boston, MA 02215, USA
    Health Qual Life Outcomes 8:28. 2010
    ..g. averted GAS disease vs. vaccine adverse events)...
  44. doi request reprint The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patients
    Benjamin P Linas
    aSection of Infectious Diseases, Department of Medicine, Boston Medical Center bDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts cDepartment of Public Health, Weill Cornell Medical College, New York, New York dDivision of General Medicine, Massachusetts General Hospital eDivision of Infectious Diseases, Massachusetts General Hospital fDepartment of Global Health and Population gDepartment of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA
    AIDS 28:365-76. 2014
    ..To evaluate the effectiveness and cost-effectiveness of strategies to treat hepatitis C virus (HCV) in HIV/HCV coinfected patients in the United States...
  45. pmc HIV treatment as prevention: issues in economic evaluation
    Till Barnighausen
    Department of Global Health and Population, Harvard School of Public Health, Boston, Massachusetts, United States of America
    PLoS Med 9:e1001263. 2012
    ..Third, the preventive effects of TasP are likely to alter the composition of the HIV-infected population over time, changing its biological and behavioral characteristics and leading to different costs and outcomes for ART...
  46. ncbi request reprint Illness transmission in the home: a possible role for alcohol-based hand gels
    Grace M Lee
    Center for Child Health Care Studies, Department of Ambulatory Care and Prevention, Harvard Pilgrim Health Care and Harvard Medical School, Boston, Massachusetts 02215, USA
    Pediatrics 115:852-60. 2005
    ..We also sought to examine potential predictors of reduced illness transmission in the home in a secondary analysis...
  47. ncbi request reprint Can we reverse the HIV/AIDS pandemic with an expanded response?
    John Stover
    Futures Group International, Glastonbury, CT, USA
    Lancet 360:73-7. 2002
    ..Analyses suggest that if the successes achieved in some countries in prevention of transmission can be expanded to a global scale by 2005, about 29 million new infections could be prevented by 2010...
  48. doi request reprint Impact of HIV on novel therapies for tuberculosis control
    Maria S Sanchez
    Department of Environmental Science, Policy and Management, University of California, Berkeley, California 94720 3114, USA
    AIDS 22:963-72. 2008
    ..We investigated how tuberculosis is impacted by reducing treatment duration alone or combined with enhanced case detection and/or cure under different HIV prevalence levels...
  49. ncbi request reprint The global impact of scaling up HIV/AIDS prevention programs in low- and middle-income countries
    John Stover
    Futures Group Constella, Glastonbury, CT 06033, USA
    Science 311:1474-6. 2006
    ..Thus, greater spending on prevention now would not only prevent more than half the new infections that would occur from 2005 to 2015 but would actually produce a net financial saving as future costs for treatment and care are averted...
  50. ncbi request reprint [Priority setting for health interventions in Mexico's System of Social Protection in Health]
    Eduardo Gonzalez-Pier
    Unidad de Análisis Económico, Secretaria de Salud, Mexico, Paseo de la Reforma 450, PH, Col Juárez, 06600 Mexico, DF, Mexico
    Salud Publica Mex 49:S37-52. 2007
    ....
  51. ncbi request reprint Quantification of health states with rank-based nonmetric multidimensional scaling
    Paul F M Krabbe
    Department of Medical Technology Assessment 138, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
    Med Decis Making 27:395-405. 2007
    ..This methodology is based on the ranking of differences between health states combined with an associated scaling model that transforms the individual rank data into group values on the interval level...
  52. ncbi request reprint Estimating the net effect of HIV on child mortality in African populations affected by generalized HIV epidemics
    Milly Marston
    London School of Hygiene and Tropical Medicine, London, United Kingdom
    J Acquir Immune Defic Syndr 38:219-27. 2005
    ..The curve also predicts 13% net survival at 10 years using constraints based on survival of infected adults...
  53. ncbi request reprint Priority setting for health interventions in Mexico's System of Social Protection in Health
    Eduardo Gonzalez-Pier
    Mexican Ministry of Health, Mexico City, Mexico
    Lancet 368:1608-18. 2006
    ....
  54. ncbi request reprint Global burden of disease 2005: call for collaborators
    Christopher J L Murray
    Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA 98104, USA
    Lancet 370:109-10. 2007
  55. ncbi request reprint Enlightened self-interest and the control of tuberculosis
    Barry R Bloom
    N Engl J Med 353:1057-9. 2005